Attana AB

Attana in Action

admin — Mon, 23 Jan 2012 09:11:51 +0200

Stockholm, Sweden, Jan. 23, 2012 - Attana has today released the events schedule for the first months of 2012. Participation is scheduled at exhibitions and conferences on three continents during February, March and April. The events include, amongst others, the Discovery Summit in Cannes and PEGS in Boston.

At the events Attana will present the latest product news and application development.

Why bridge the gap between biochemical and cell based assays?

admin — Fri, 18 Nov 2011 10:00:00 +0200

Attana has released a product note explaining the benefits of bridging the gap between traditional biochemical biosensors and cell based assays

Stockholm, Sweden, November 18, 2011 - Today, Attana released a product note explaining the benefits of bridging the gap between traditional biochemical biosensors and cell based assays.

Global customer proximity for Swedish biotech company Attana AB

admin — Wed, 19 Oct 2011 08:30:54 +0200

Investing in global customer proximity is the new strategy for Swedish biosensor company Attana AB. Last week, the company announced an extended distribution agreement under which Tecan now will distribute Attana's label-free QCM biosensors in Europe as well.

Tecan and Attana extend distribution agreement

admin — Tue, 11 Oct 2011 09:00:00 +0200

Tecan and Attana AB have announced an extended distribution agreement under which Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology in Europe.

Attana AB and Layerlab AB sign global distribution agreement

admin — Tue, 20 Sep 2011 09:23:34 +0200

Attana and Layerlab announced today that they have signed a global distribution agreement under which Attana will distribute memLAYER™ for utilization together with Attana’s QCM biosensors. With biosensor users in mind, both Attana and Layerlab can now offer the market new and improved application methods.

Monitoring Aggregation in Biotherapeutics

admin — Tue, 28 Jun 2011 09:00:00 +0200

Lonza Biologics and Attana have collaborated on an article in Innovations in Pharmaceutical Technology.

The combination of computational and protein engineering tools with novel orthogonal methods of measuring aggregation can be used to assess the developability of biopharm products in the early stages of development, thereby reducing the level of risk in later stages.

Cell-Based Biosensors: A QCM Approach to Membrane Protein Interaction Studies

admin — Mon, 13 Jun 2011 09:00:00 +0200

American Laboratory has published an article featuring the Attana Technology.

Attana highlighted on Today in America with Terry Bradshaw

admin — Thu, 03 Mar 2011 11:59:52 +0200

Attana AB, developer of biosensors, is proud to announce our particpation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series.

Event Updates

admin — Tue, 01 Mar 2011 17:14:52 +0200

We are gearing up for an exciting month of March with many interesting events. Just in the last two weeks of the month we will be showing the latest Attana systems at conferences in France, China, Switzerland and the US.

To ensure you don't miss out, please visit our Events section by clicking here.

We look forward to seeing you in the near future.

Tecan Group and Attana AB sign distribution agreement in North America

admin — Wed, 12 Jan 2011 19:52:44 +0200

Tecan and Attana now offering the biopharmaceutical society complete solutions within sample handling and systems for detection and full characterization for molecular interactions.